Preventive effect of ACE inhibitor on interstitial myofibroblast formation and matrix deposition in a nephrotic model

References

• Risdon RA, Sloper JC, Wardener HE. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 1968; 2: 363–366
   PubMed Web of Science ®Google Scholar
• Bohle A, Strutz F, Muller GA. On the pathogenesis of chronic renal failure in primary glomennlopathies: A view from the interstitium. Exp Nephrol 1994; 2: 205–210
   PubMedGoogle Scholar
• Tang WW, Feng L, Mathison JC, Wilson CB. Cytokine expression, upregulation of intercellular adhesion molecule-1, and leukocyte infiltration in experimental tubulointerstitial nephritis. Lab Invest 1994; 70: 631–638
   PubMed Web of Science ®Google Scholar
• Fine LG, Norman JT. Ong A Cell-cell cross-talk in the pathogenesis of renal interstitial fibrosis. Kidney Int 1995; 47: 548–550, suppl 49
   Google Scholar
• Ong AC, Fine LG. Tubular-derived growth factors and cytokines in the pathogenesis of tubulointerstitial fibrosis: Implications for human renal disease progression. Am J Kidney Dis 1994; 23: 205–209
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM. Renal injury from angiotensin II-mediated hypertension. Hypertension 1992; 19: 464–474
   PubMed Web of Science ®Google Scholar
• Arai M, Wada A, Isaka Y, Akagi Y, Sugiura T, Miyazaki M, Moriyama T, Kaneda Y, Naruse K, Naruse M, Orita Y, Ando A, Kamada T, Ueda N, Imai E. In vivo transfection of genes for resin and angiotensinogen into the glomerular cells induced phenotypic change of the mesangial cells and glomerular sclerosis. Biochem Biophys Res Commun 1995; 206: 525–532
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzl P, Gordon K, Gown AM. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. J Clin Invest 1993; 92: 2597–2601
   PubMedGoogle Scholar
• Kliem V, Johnson RJ, Alpers CE, Yoshimura A, Couser WG, Koch KM, Floege J. Mechanisms involved in the pathogenesis oftubulointerstitial fibrosis in 5/6-nephredomized rats. Kidney Int 1996; 49: 666–678
   PubMed Web of Science ®Google Scholar
• Hsueh WA, Do YS, Anderson PW, Law RE. Angiotensin II in cell growth and matrix production. Adv Exp Med Bid 1995; 377: 217–223
   PubMedGoogle Scholar
• Ruiz OM, Gomez GD, Alcazar R, Palacios I, Bustos C, Gonzalez S, Plaza JJ, Gonzalez E, Egido J. Involvement of angiotensin II and endothelin in matrix protein production and renal sclerosis. J Hypertens 1994; 12: 551–558, suppl 4
   Google Scholar
• Praga M, Hernandez E, Montoyo C, Andres A, Ruiope LM, Rodicio JL. Long-term beneficial effects of angiotensin-convecting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 1992; 20: 240–248
   PubMed Web of Science ®Google Scholar
• Cattran DC, Greenwood C, Ritchie S. Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: A comparison to patients receiving treatment with other antihypeitensive agents and to patients receiving no therapy. Am J Kidney Dis 1994; 23: 247–254
   PubMed Web of Science ®Google Scholar
• Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-convening enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993; 329: 1456–1462
   PubMed Web of Science ®Google Scholar
• Kurosawa T, Okamoto M, Yamada K, Yue B. Nephrosis (nap): A new mouse mutation which causes albuminuria and other symptoms of nephrosis. Mouse Genome 1993; 91: 876–878
   Google Scholar
• Tatsumi H, Satoh S, Okamoto M, Nakamura M, Asano T, Kurosawa T. Morphological studies on the kidney of the spontaneous nephrotic (ICGN) mice in the late stage. Acta Anat Nippon 1995; 70: 96–106
   Google Scholar
• Ogura A, Asano T, Suzuki O, Yamamoto Y, Noguchi Y, Kawaguchi H, Yamaguchi Y. Hereditary nephrotic syndrome with progression to renal failure in a mouse model (ICGN strain): Clinical study. Nephron 1994; 68: 239–244
   PubMedGoogle Scholar
• Mizuno S, Yue BF, Okamoto M, Horikawa Y, Kurosawa T. Diffuse glomerulosclerosis without tubular injury does not directly manifest renal dysfunction in nephrotic mice (ICGN strain). Exp Nephrol., in press
   Google Scholar
• Sakemi T, Baba N, Yoshikawa Y. Angiotensin-convening enzyme inhibition attenuates hypercholesterolemia and glomerular injury in hyperlipidemic Imai rats. Nephron 1992; 62: 315–321
   PubMedGoogle Scholar
• Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 1984; 26: 137–143
   PubMed Web of Science ®Google Scholar
• Ishidoya S, Morrissey J, McCracken R, Klahr S. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int 1996; 49: 1110–1119
   PubMed Web of Science ®Google Scholar
• Anderson S, Reinke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77: 1993–2000
   PubMed Web of Science ®Google Scholar
• Zoja C, Coma D, Bruzzi I, Foglieni C, Bertani T, Remuzzi G, Behigni N. Passive heymann nephritis: Evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury. Exp Neohrol 1996; 4: 213–221
   PubMedGoogle Scholar
• Ogura A, Fujimura H, Asano T, Koura M, Naito I, Kobayashi Y. Early ultrastrudural glomerular alterations in neonatal nephrotic mice (ICGN strain). Vet Pathol 1995; 32: 321–323
   PubMedGoogle Scholar
• Nahas AME, Mudhancta-Kubara EC, Zhang G, Adam A, Goumenos D. Phenotypic modulation of renal cells during experimental and clinical renal scarring. Kidney Int 1996; 49: 523–527, Suppl 54
   Google Scholar
• Tang WW, Ulieh TR, Lacey DL, Hill DC, Qi M, Kaufman SA, Van GY, Tarpley JE, Yee JS. Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 1996; 148: 1169–1180
   PubMed Web of Science ®Google Scholar
• Mizuno S, Horikawa Y, Okamoto M, Kurosawa T. ACE inhibition suppresses tubular expression of PDGF in a nephrotic mouse model. Nephron (letter), in press
   Google Scholar
• Inserra F, Romano LA, Cavanagh EM, Ercole L, Ferder LF, Gomez RA. Renal interstitial sclerosis in aging: Effects of enalapril and nifedipine. J Am Soc Nephrol 1996; 7: 676–680
   PubMedGoogle Scholar
• Fogo A, Yoshida Y, Glick AD, Homma T, Ichikawa I. Serial micropuncturc analysis of glomerular function in two rat models of glomerular sclerosis. J Clin Invest 1988; 82: 322–330
   PubMed Web of Science ®Google Scholar
• Kakinuma Y, Kawamura T, Bills T, Yoshioka T, Ichikawa I, Fogo A. Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney hit 1992; 42: 46–55
   PubMed Web of Science ®Google Scholar